髓系细胞CSF1R表达降低对慢性淋巴细胞白血病进展影响有限
该研究在Eμ-TCL1慢性淋巴细胞白血病(CLL)小鼠模型中引入Csf1r单倍剂量不足,发现循环单核细胞Csf1r表达降低,但组织巨噬细胞表达及单核/巨噬细胞总数无显著变化。Csf1r水平降低的小鼠早期白血病负荷减少,但随疾病进展该效应消失,总生存与对照相似;体外共培养显示敲低CSF1R不影响患者来源CLL细胞存活或迁移。提示单纯降低CSF1R表达对CLL进展影响有限。
要点
- Csf1r单倍剂量不足降低循环单核细胞Csf1r表达,但不影响组织巨噬细胞表达及髓系细胞总数。
- 低Csf1r的Eμ-TCL1小鼠早期白血病减少,但进展后效应消失,总生存与对照相似。
- 体外敲低CSF1R不影响患者来源CLL细胞存活或迁移,靶向CSF1R需更强巨噬细胞清除或联合治疗。
核心结论
- 单纯降低CSF1R表达对CLL疾病进展影响有限,靶向CSF1R治疗可能需要更强巨噬细胞清除或联合其他药物。
研究设计与样本
- 研究采用Eμ-TCL1转基因CLL小鼠引入Csf1r单倍剂量不足,观察髓系细胞、Csf1r表达及白血病进展。
- 体外共培养实验检测敲低CSF1R对患者来源CLL细胞存活和迁移的影响。
主要发现
- Csf1r单倍剂量不足降低循环单核细胞Csf1r表达,但不显著损害组织巨噬细胞Csf1r表达。
- 血液和淋巴组织中单核细胞与巨噬细胞总数未因Csf1r单倍剂量不足而改变。
- 低Csf1r的Eμ-TCL1小鼠早期白血病减少,但随疾病进展效应消失,总生存与对照相似。
- 体外敲低CSF1R不影响患者来源CLL细胞的存活或迁移。
临床怎么用
- 提示临床开发CSF1R靶向治疗CLL时,单纯降低CSF1R表达可能疗效有限。
- 未来策略可考虑更强效的巨噬细胞清除或与其他药物联合。
局限性
- 研究基于Eμ-TCL1小鼠模型和体外共培养,结论需在人体临床研究中验证。
- 未明确CSF1R表达降低对组织巨噬细胞功能的细微影响。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
Targeting the colony-stimulating factor 1 receptor (CSF1R) to remove tumour-associated macrophages is being explored as cancer therapy. This strategy may be relevant for chronic lymphocytic leukaemia (CLL), which strongly depends on support from myeloid cells. However, it is unclear how CSF1R expression affects the CLL microenvironment and leukaemic progression. To examine this question, we created Eμ-TCL1 transgenic mice for CLL with Csf1r haploinsufficiency to investigate changes in myeloid cells, Csf1r expression and leukaemia progression. Csf1r haploinsufficiency reduced Csf1r expression on circulating monocytes, but did not significantly impair its expression in tissue macrophages or change the overall numbers of monocytes or macrophages in blood and lymphoid tissues. Eμ-TCL1 transgenic mice with lower Csf1r levels had less leukaemia during early disease, but this effect faded with disease progression, and their overall survival was similar to controls. Furthermore, in vitro co-culture demonstrates that depletion of CSF1R expression on cell lines did not affect the survival or migration of patient-derived CLL cells. In summary, our results show that while the CSF1R pathway is important for maintaining the myeloid cells that support CLL, simply reducing CSF1R expression has only a limited effect on disease progression. Attempts to target the CSF1R for leukaemic therapy might benefit from a stronger depletion of macrophages or the combination with other agents.
引用
- Rosen N, Rodriguez-Real G, Vom Stein AF, et al. Reduced colony-stimulating factor 1 receptor expression in myeloid cells has limited impact on chronic lymphocytic leukaemia progression. Br J Haematol. 2026. PMID: 42503043. doi:10.1111/bjh.70700
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。